切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2020, Vol. 16 ›› Issue (06) : 695 -701. doi: 10.3877/cma.j.issn.1673-5250.2020.06.011

所属专题: 文献

论著

儿童Ⅰ型葡萄糖转运子缺陷综合征诊治分析并文献复习
杨贵云1, 侯显玉1, 田茂强2, 袁颖1, 李福兴3,()   
  1. 1. 赤水市人民医院儿科,贵州遵义 564700
    2. 遵义医科大学附属医院儿内科,贵州 563000
    3. 同济大学附属同济医院儿科,上海 200065
  • 收稿日期:2020-01-17 修回日期:2020-11-13 出版日期:2020-12-01
  • 通信作者: 李福兴

Analysis of diagnosis and treatment of children with glucose transporter 1 deficiency syndrome and literature review

Guiyun Yang1, Xianyu Hou1, Maoqiang Tian2, Ying Yuan1, Fuxing Li3,()   

  1. 1. Department of Pediatrics, Chishui People′s Hospital, Zunyi 564700, Guizhou Province, China
    2. Department of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China
    3. Department of Pediatrics, Tongji Hospital of Tongji University, Shanghai 200065, China
  • Received:2020-01-17 Revised:2020-11-13 Published:2020-12-01
  • Corresponding author: Fuxing Li
  • Supported by:
    National Natural Science Foundation of China(81760309)
引用本文:

杨贵云, 侯显玉, 田茂强, 袁颖, 李福兴. 儿童Ⅰ型葡萄糖转运子缺陷综合征诊治分析并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2020, 16(06): 695-701.

Guiyun Yang, Xianyu Hou, Maoqiang Tian, Ying Yuan, Fuxing Li. Analysis of diagnosis and treatment of children with glucose transporter 1 deficiency syndrome and literature review[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2020, 16(06): 695-701.

目的

探讨我国儿童Ⅰ型葡萄糖转运子缺陷综合征(GLUTl-DS)的临床特征。

方法

选择2018年6月,于贵州赤水市人民医院诊治的1例女性GLUTl-DS患儿为研究对象,回顾性分析其临床病例资料。对国内外数据库中,关于我国GLUTl-DS患儿的中、英文文献(临床资料基本完整)进行文献复习,总结GLUTl-DS患儿的临床表现、诊断、治疗措施与转归。本研究经病例收集医院伦理委员会批准(审批文号:201801),对患儿的诊治,均征得患儿监护人知情同意。

结果

①本例GLUTl-DS患儿为女性,就诊年龄为2岁4个月,主要临床表现为发作性面部发绀、小头畸形、发育落后及运动障碍。患儿视频脑电图异常,脑脊液葡萄糖、以及脑脊液葡萄糖与血糖浓度比值(脑脊液葡萄糖/血糖)均降低,基因检测(Sanger法)提示患儿第5外显子C.661G>A(p.E221K)杂合错义突变(来源于其父亲)。患儿对生酮饮食(KD)治疗不耐受,院外采取中医康复治疗6个月后效果欠佳;随访至3岁11个月龄,运动、语言发育较正常儿童均明显落后。②文献复习结果:纳入关于我国GLUTl-DS患儿研究的中、英文文献共7篇,纳入研究的GLUTl-DS患儿为17例,结合本院1例,故纳入18例我国GLUTl-DS患儿临床资料总结如下。本病男性∶女性发病率为10∶8,中位发病年龄为7个月,中位诊断年龄为55个月;以痫性发作(94.4%,17/18),发育落后(88.9%,16/18),共济失调(72.2%,13/18)为主要临床表现;18例(100.0%)患儿的脑脊液葡萄糖浓度、脑脊液葡萄糖/血糖均降低;17例接受SLC2A1基因检测患儿中,15例为该基因异常。11例采取KD治疗患儿中,8例症状明显缓解,3例对KD治疗不耐受而停止治疗;对4例采取增加进食次数及糖分摄入后,也取得较好疗效。

结论

GLUTl-DS患儿根据典型临床表现、实验室检查及SLC2A1基因检测结果,可明确诊断。对疑似或临床诊断为GLUTl-DS患儿,尽早开始KD治疗,或增加进食次数、糖分摄入治疗等,可改善患儿预后。

Objective

To investigate clinical features of Chinese children with glucose transporter 1 deficiency syndrome (GLUT1-DS).

Methods

By retrospectively analytic method, clinical data of a girl with GLUTl-DS who was diagnosed and treated in Chishui People′s Hospital in June 2018 was selected. The clinical manifestation, diagnosis, treatment measures and sequelae of GLUT1-DS of domestic population were summarized by reviewing Chinese and English literature of GLUT1-DS with basically complete clinical data in domestic and foreign databases. This study was approved by the Ethics Committee of Cishui People′s Hospital (Approval No. 201801). Informed consent was obtained from the guardian of this child for the diagnosis and treatment.

Results

① The girl was diagnosed with GLUTl-DS at 2 years and 4 months old as main clinical manifestations of paroxysmal facial cyanosis, microcephaly, developmental retardation and dyskinesia. Monitoring results of video EEG was abnormal, levels of cerebrospinal fluid glucose, and levels of cerebrospinal fluid glucose to levels of plasma glucose ratio (cerebrospinal fluid glucose/plasma glucose) were both decreased. Gene detection (Sanger method) showed heterozygous missense mutation of exon 5: C. 661G>A (p.E221K) (from her father). The girl was intolerant to ketogenic diet (KD) therapy and response poorly to 6 months of Traditional Chinese Medicine rehabilitation treatment in other hospital. After followed up to 3 years and 11 months old, motor and language development of the girl was obviously behind that of normal children. ② Results of literature review: the clinical data of 18 cases with GLUTl-DS in China including 17 cases from 7 pieces of Chinese or English literature and one case in this study were summarized as follows. The male to female ratio of GLUTl-DS incidence was 10∶8, the median age of onset was 7 months, and the median age at diagnosis was 55 months. Main clinical symptoms were epileptic seizures (94.4%, 17/18), development retardation (88.9%, 16/18) and ataxia (72.2%, 13/18). The cerebrospinal fluid glucose concentration, and cerebrospinal fluid glucose/plasma glucose decreased in all the 18 cases (100.0%). SLC2A1 gene screening were performed in 17 cases, and revealed gene mutation in 15 cases. KD therapy were administered in 11 cases, and symptoms were effectively controlled in 8 cases but another 3 cases discontinued KD therapy due to intolerance. Four cases achieved good treatment results by increase the frequency of meals and high carbohydrate intake.

Conclusions

Typical clinical manifestations, laboratory examination and SLC2A1 gene detection results, can confirm the diagnosis of GLUTl-DS. For suspected or clinically diagnosed patients with GLUTl-DS, early start of KD therapy or increase the frequency of eating or sugar intake evidently can improve their prognosis.

图1 本例GLUT1-DS患儿(女性,2岁4个月龄)及其父母SLC2A1基因Sanger法测序图[红色箭头所示为患儿及其父亲均存在第5外显子C.661G>A(p.E221K)杂合错义突变,患儿母亲该位点无突变]
表1 本例及文献纳入研究的17例GLUTl-DS患儿临床病例资料分析
病例(No.) 文献(第1作者,文献发表年) 发病年龄 诊断年龄 性别 痫性发作 智力、运动发育落后 共济失调 踝阵挛 语言障碍 小头畸形
1 刘燕燕[5],2013 41 d 3个月
2 刘燕燕[5],2013 60 d 3个月
3 刘燕燕[5],2013 33 d 6岁
4 刘燕燕[5],2013 3岁7个月 7岁
5 刘燕燕[5],2013 6岁2个月 6岁5个月
6 刘燕燕[5],2013 2岁10个月 5岁
7 李晓华[6],2014 6个月 6个月
8 李晓华[6],2014 73 d 4个月
9 余宾[7],2015 2个月 2岁6个月
10 叶小飞[8],2012 2个月 2个月
11 段丽芬[9],2016 9个月 6岁1个月
12 Fung[10],2010 18个月 5岁
13 Fung[10],2010 8个月 17岁
14 姬辛娜[11],2018 11个月 4岁2个月
15 姬辛娜[11],2018 15个月 11岁1个月
16 姬辛娜[11],2018 2个月 3岁4个月
17 姬辛娜[11],2018 6个月 6岁
18 杨贵云,2020 1岁 2岁2个月
病例(No.) 其他症状 视频脑电图 头颅CT或MRI SLC2A1基因检测 脑脊液葡萄糖浓度(mmol/L) 脑脊液葡萄糖/血糖
1 多灶痫样放电 轻度脑萎缩 2号外显子大片段缺失 1.10~2.45,平均为1.68b 0.16~0.51,平均为0.34b
2 正常 正常 5号外显子C.741G>A(E247K)    
3 晨起及餐前发作性困倦、无力 正常 双侧脑室饱满 5号外显子C.599delA    
4 发作性无力、睡眠增多、意识障碍 正常 脑白质发育迟缓 6号外显子C.761delA    
5 发作性精神症状 慢波、全导和局灶痫样放电 正常 9号外显子C.1148C>A(P383H)    
6 发作性无力 正常 正常 9号外显子C.1198C>T(R400C)    
7 肌张力低下 背景为弥散性2~ 3 Hz低波幅δ波 未作 未发现基因突变点 1.60 0.24
8 左膝腱反射略活跃 双额及中央顶、枕区多灶性棘波、尖波、多棘波散发或簇发 未作 8号外显子C.972+1G>C 2.30 0.32
9 运动障碍 背景活动慢,以中高幅4~5 Hz θ波为主 正常 C.516 +2T>G(杂合突变)a 1.35 0.32
10 δ活动为主 正常 未描述 1.10 0.21
11 晨起头痛,空腹行走不稳 广泛性棘慢波发放 正常 4号外显子C.350_385del 1.87 0.36
12 肌张力障碍 正常 正常 2号外显子240delC 1.80 0.38
13 饥饿时发作性无力 正常 正常 8号外显子杂合突变c.1176 C>T(R333W) 1.90 0.38
14 空腹或玩耍时发作性肢体瘫痪、肌张力异常、震颤 全导阵发性高幅慢波,夹杂癫痫放电 正常 6号外显子c.787_791delTTCCG(p.F263Lfs) 均降低,但是未提供具体数据c 均降低,但是未提供具体数据c
15 肌张力异常,发作性眼球运动障碍 右侧大脑半球持续性慢波,右侧大脑半球及左侧额区癫痫放电 双侧额叶皮层下异常信号 4号外显子c.376G>A(p.R126C)    
16 震颤、肌张力异常,发作性眼球运动障碍 全导癫痫放电,以额区、枕区显著 双侧额、颞叶脑沟增宽 6号外显子c.377G>A(p.R126H)    
17 肌张力异常 双侧额、中央及额中线区偶见不典型尖波 正常 6号外显子c.688_689 insT    
18 肌张力升高 醒睡各期大量弥散性快波或快波节律发放,睡眠期多灶性棘波、尖波、棘慢波发放 正常 5号外显子c.661G>A 2.43 0.44
[1]
Gras D, Cousin C, Kappeler C, et al. A simple blood test expedites the diagnosis of glucose transporter type 1 deficiency syndrome[J]. Ann Neurol, 2017, 82(1): 133-138. DOI: 10.1002/ana.24970.
[2]
Gras D, Roze E, Caillet S, et al. GLUT1 deficiency syndrome: an update[J]. Rev Neurol (Paris), 2014, 170(2): 91-99. DOI: 10.1016/j.neurol.2013.09.005.
[3]
Tang M, Gao G, Rueda CB, et al. Brain microvasculature defects and GLUT1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein[J]. Nat Commun, 2017, 8: 14152. DOI: 10.1038/ncomms14152.
[4]
Kass HR, Winesett SP, Bessone SK, et al. Use of dietary therapies amongst patients with GLUT1 deficiency syndrome[J]. Seizure, 2016, 35: 83-87. DOI: 10.1016/j.seizure.2016.01.011.
[5]
刘燕燕,包新华,王爽,等. 葡萄糖转运子1缺乏综合征的临床特点与基因突变分析[J]. 中华儿科杂志,2013, 51(6): 443-447. DOI: 10.3760/cma.j.issn.0578-1310.2013.06.011.
[6]
李晓华,朝鲁门其其格,王继春,等. 葡萄糖转运子-1缺乏综合征2例[J]. 中华实用儿科临床杂志,2014, 29(20): 1593-1594. DOI: 10.3760/j.issn.2095-428X.2014.20.022.
[7]
余宾,龙易勤. 葡萄糖转运蛋白1缺陷综合征误诊剖析[J]. 临床误诊误治,2015, (9): 54-55. DOI: 10.3969/j.issn.1002-3429.2015.09.023.
[8]
叶小飞,赵忠礼,杨斌. 1型葡萄糖转运体缺陷综合征一例报告及文献复习[J]. 中国优生与遗传杂志,2012, 20(11): 124-126.
[9]
段丽芬,王惠萍,孙莹,等. 1型葡萄糖转运体缺陷综合征临床特征并文献复习[J]. 中国小儿急救医学,2016, 23(5): 337-341. DOI: 10.3760/cma.j.issn.1673-4912.2016.05.012.
[10]
Fung EL, Ho YY, Hui J, et al. First report of GLUT1 deficiency syndrome in Chinese patients with novel and hot spot mutations in SLC2A1 gene[J]. Brain Dev, 2011, 33(2): 170-173. DOI: 10.1016/j.braindev.2010.03.009.
[11]
姬辛娜,徐翠娟,高志杰,等. 葡萄糖转运子1缺陷综合征运动障碍特点和诊疗分析[J]. 中国当代儿科杂志,2018, 20(3): 209-213. DOI: 10.7499/j.issn.1008-8830.2018.03.009.
[12]
Coman DJ, Sinclair KG, Burke CJ, et al. Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome[J]. J Paediatr Child Health, 2006, 42(5): 263-267. DOI: 10.1111/j.1440-1754.2006.00852.x.
[13]
Juozapaite S, Praninskiene R, Burnyte B, et al. Novel mutation in a patient with late onset GLUT1 deficiency syndrome[J]. Brain Dev, 2017, 39(4): 352-355. DOI: 10.1016/j.braindev.2016.11.007.
[14]
Tagliabue A, Ferraris C, Uggeri F, et al. Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 deficiency syndrome: a 3-month prospective observational study[J]. Clin Nutr ESPEN, 2017, 17: 33-37. DOI: 10.1016/j.clnesp.2016.11.003.
[15]
Amalou S, Gras D, Ilea A, et al. Use of modified atkins diet in glucose transporter type 1 deficiency syndrome[J]. Dev Med Child Neurol, 2016, 58(11): 1193-1199. DOI: 10.1111/dmcn.13167.
[16]
Ito Y, Takahashi S, Kagitani-Shimono K, et al. Nationwide survey of glucose transporter-1 deficiency syndrome (GLUT-1DS) in Japan[J]. Brain Dev, 2015, 37(8): 780-789. DOI: 10.1016/j.braindev.2014.11.006.
[17]
Deprez L, Jansen A, De Jonghe P. Genetics of epilepsy syndromes starting in the first year of life[J]. Neurology, 2009, 72(3): 273-281. DOI: 10.1212/01.wnl.0000339494.76377.d6.
[18]
O′Callaghan FJ, Edwards SW, Alber FD, et al. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial[J]. Lancet Neurol, 2017, 16(1): 33-42. DOI: 10.1016/S1474-4422(16)30294-0.
[19]
Belcastro V, Giordano L, Pruna D, et al. Follow-up study of idiopathic generalized epilepsy with associated absence seizure and myoclonic epilepsy of infancy[J]. Epilepsy Res, 2017, 136: 123-125. DOI: 10.1016/j.eplepsyres.2017.08.001.
[20]
Fulton SP, Van Poppel K, McGregor AL, et al. Vagus nerve stimulation in intractable epilepsy associated with SCN1A gene abnormalities[J]. J Child Neurol, 2017, 32(5): 494-498. DOI: 10.1177/0883073816687221.
[21]
Fujii T, Ito Y, Takahashi S, et al. Outcome of ketogenic diets in GLUT1 deficiency syndrome in Japan: a nationwide survey[J]. Brain Dev, 2016, 38(7): 628-637. DOI: 10.1016/j.braindev.2016.01.002.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[3] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[4] 王雅楠, 刘丹, 曹正浓, 贾慧敏. 儿童迟发性先天性膈疝患儿的临床诊治特点分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 410-419.
[5] 陈桂华, 钟小玲, 谢雨, 王慧, 谢江, 杨涛毅. 合并肝脏疾病特殊健康状态儿童疫苗预防接种及时性临床分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 431-439.
[6] 雷丽莉, 于晓峰, 王媛媛, 徐迎军. 人鼻病毒感染喘息急性发作儿童外周血NLRP3和TLR4水平及临床意义[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 440-445.
[7] 顾盼盼, 董传莉, 宋梦瑶, 瞿色华, 杨小迪, 周瑞. 不完全性川崎病患儿临床特征及冠状动脉损害情况分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 446-451.
[8] 张梦思, 麻艺群, 蒙礼娟, 朱辉, 付晋凤. 压力手套与指蹼加压带及泡沫型硅凝胶贴膜联合应用于儿童瘢痕性并指术后的效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 329-334.
[9] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[10] 丁荷蓓, 王珣, 陈为国. 七氟烷吸入麻醉与异丙酚静脉麻醉在儿童腹股沟斜疝手术中的应用比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 570-574.
[11] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[12] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[13] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[14] 陈晓胜, 何佳, 刘方, 吴蕊, 杨海涛, 樊晓寒. 直立倾斜试验诱发31 秒心脏停搏的植入心脏起搏器儿童一例并文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 488-494.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要